Cambridge Epigenetix raises $21M in series B round

Cambridge Epigenetix Ltd. (Babraham, U.K.) raised $21 million in a series B round led by new investor GV. New investor Sequoia Capital also participated, as did existing investors New Science Ventures, Syncona Partners and Cambridge Enterprise.

The University of Cambridge spinout is developing kits to sequence and distinguish between methylated and hydroxymethylated base pairs at single-base resolution based on the company's TrueMethyl oxidative bisulfite sequencing (oxBS-Seq) technology. ...